Fact Sheet: Oxytetracycline Injectable INAD 9027

for detailed information, see INAD study protocol, use link on the left

The following links are specific to:
Oxtetracycline Injectable

Drug summary & history

List of FDA-Approved drugs

Drug forms to be completed

Examples of completed forms

INAD study protocol

Material Safety Data Sheet
(MSDS)

Study Summaries

Print this drug fact sheet

Print all drug fact sheets

INAD signup form (Federal facilities)

INAD signup form (other facilities)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of oxytetracycline (OTC) injectable therapy to control mortality caused by certain bacterial diseases.
Drug name: Liquamycin® LA-200®
Source of drug: Pfizer, Inc.
Address: Pfizer Animal Health
700 Portage Road
RIC-190-43
Kalamazoo, MI 49001-0199
Contact: Dr. Mark Subramanyam
Phone: 269-833-3388
Fax: 269-833-2707
Email: mark.subramanyam@pfizer.com
Target pathogen(s): Bacterial pathogens susceptible to oxytetracycline.
Method of administration: IP or IM injection
Treatment dosage: 20 milligrams OTC per kilogram body weight
Treatment regimen: Option A: Single injection (all salmonids)
Option B: Single injection (all non-salmonids)
Withdrawal period:

30 days

No withdrawal period is required for treated fish that will not be susceptible to legal harvest for at least 30 days post-treatment.

Required test parameters: Investigator must collect mortality data throughout the 5-day pre-treatment, treatment, and 30-day post-treatment period. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Limitations or restrictions on use:

Investigator must follow all instructions in the Study Protocol for INAD 9027 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Drug discharge must be in compliance with local NPDES permitting requirements.

Required INAD fee: $400.00 per facility per year
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.